| The unintended consequences of COVID-19 vaccine policy: why mandates, passports and restrictions may cause more harm than good K Bardosh, A De Figueiredo, R Gur-Arie, E Jamrozik, J Doidge, ... BMJ Global Health 7 (5), e008684, 2022 | 284 | 2022 |
| COVID-19 human challenge studies: ethical issues E Jamrozik, MJ Selgelid The Lancet Infectious Diseases 20 (8), e198-e203, 2020 | 162 | 2020 |
| Ethics of controlled human infection to address COVID-19 SK Shah, FG Miller, TC Darton, D Duenas, C Emerson, HF Lynch, ... Science 368 (6493), 832-834, 2020 | 136 | 2020 |
| No jab, no job? Ethical issues in mandatory COVID-19 vaccination of healthcare personnel R Gur-Arie, E Jamrozik, P Kingori BMJ global health 6 (2), e004877, 2021 | 116 | 2021 |
| Risk factors for adult‐onset asthma: a 14‐year longitudinal study E Jamrozik, MW Knuiman, A James, M Divitini, AW Musk Respirology 14 (6), 814-821, 2009 | 80 | 2009 |
| Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group E Jamrozik, K Littler, S Bull, C Emerson, G Kang, M Kapulu, E Rey, ... Vaccine 39 (4), 633-640, 2021 | 60 | 2021 |
| COVID-19 vaccine boosters for young adults: a risk benefit assessment and ethical analysis of mandate policies at universities K Bardosh, A Krug, E Jamrozik, T Lemmens, S Keshavjee, V Prasad, ... Journal of Medical Ethics 50 (2), 126-138, 2024 | 57 | 2024 |
| Human challenge studies in endemic settings: ethical and regulatory issues E Jamrozik, MJ Selgelid Springer Nature, 2021 | 54 | 2021 |
| Ethics and drug resistance: collective responsibility for global public health E Jamrozik, M Selgelid Springer Nature, 2020 | 52 | 2020 |
| Ethical aspects of malaria control and research E Jamrozik, V de la Fuente-Nunez, A Reis, P Ringwald, MJ Selgelid Malaria journal 14, 1-7, 2015 | 45 | 2015 |
| Respiratory health issues in the Asia–Pacific region: An overview E Jamrozik, AW Musk Respirology 16 (1), 3-12, 2011 | 45 | 2011 |
| Human infection challenge studies in endemic settings and/or low-income and middle-income countries: key points of ethical consensus and controversy E Jamrozik, MJ Selgelid Journal of Medical Ethics 46 (9), 601-609, 2020 | 38 | 2020 |
| Ethical challenges posed by human infection challenge studies in endemic settings MJ Selgelid, E Jamrozik Indian journal of medical ethics 3 (4), 263, 2018 | 36 | 2018 |
| Victims, vectors and villains: are those who opt out of vaccination morally responsible for the deaths of others? E Jamrozik, T Handfield, MJ Selgelid Journal of medical ethics 42 (12), 762-768, 2016 | 35 | 2016 |
| Validity of self-reported versus hospital-coded diagnosis of stroke: a cross-sectional and longitudinal study E Jamrozik, Z Hyde, H Alfonso, L Flicker, O Almeida, B Yeap, P Norman, ... Cerebrovascular Diseases 37 (4), 256-262, 2014 | 33 | 2014 |
| Drug-resistant infection: Causes, consequences, and responses E Jamrozik, MJ Selgelid Ethics and drug resistance: Collective responsibility for global public …, 2020 | 31 | 2020 |
| Ethical issues surrounding controlled human infection challenge studies in endemic low‐and middle‐income countries E Jamrozik, MJ Selgelid Bioethics 34 (8), 797-808, 2020 | 29 | 2020 |
| Evidence‐poor medicine: just how evidence‐based are Australian clinical practice guidelines? C Venus, E Jamrozik Internal medicine journal 50 (1), 30-37, 2020 | 26 | 2020 |
| A systematic review of human challenge trials, designs, and safety J Adams-Phipps, D Toomey, W Więcek, V Schmit, J Wilkinson, K Scholl, ... Clinical Infectious Diseases 76 (4), 609-619, 2023 | 25 | 2023 |
| Against COVID‐19 vaccination of healthy children SR Kraaijeveld, R Gur‐Arie, E Jamrozik Bioethics 36 (6), 687-698, 2022 | 25 | 2022 |
